Latest study demonstrates a machine learning model improved Bio-RFID™ sensor’s accuracy for predicting blood glucose, using the Dexcom G6® as reference device “A MARD of 12.9% at this stage in our ...
Study demonstrates the Bio-RFID™ sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device From December 2022 through February ...
Heart blockage, also known as coronary artery disease or CAD, happens when there is an obstruction or narrowing of the arteries supplying blood to your heart muscle due to plaque. Eventually, it ...
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® ...
Endometriosis is a chronic condition affecting approximately 190 million women and teenage girls globally. It can cause severe pelvic pain, painful periods, and infertility. It occurs when tissue ...
Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp's non-invasive blood-based diagnostic test powered by GENFIT's proprietary NIS4® technologyFocuses on patie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results